Re:Launch HN: Darmiyan (YC S17) – Early Detection of Alzheim...
by x0x0 on Wednesday August 23, 2017 @06:18PM
(#15085694)
Why do you think a lack of ability to detect/quantify these micro-structural abnormalities is hindering clinical trials? Is it a problem of detection lag?
How will your tech enable a disease-modifying treatment? Is the hypothesis your tech is the first way we can even measure?
Are you using standard MRIs and just a layer of software, or do you require some sort of special physical device?
This is all curiosity btw; I love the idea. I used to work on software for confocal microscopy and protein melting curves (to be clear, two different labs) before selling out and working on ads.
How will your tech enable a disease-modifying treatment? Is the hypothesis your tech is the first way we can even measure?
Are you using standard MRIs and just a layer of software, or do you require some sort of special physical device?
This is all curiosity btw; I love the idea. I used to work on software for confocal microscopy and protein melting curves (to be clear, two different labs) before selling out and working on ads.